Report on a child with neurofibromatosis type 2 and unilateral moyamoya: further evidence of cerebral vasculopathy in NF2
Letter to Editor
Recently, Lascelles et al. reported on three children with neurofibromatosis type 2 (NF2) and intracerebral vasculopathy and/or ischemic strokes . In our opinion, this report is particularly relevant given that our understanding of features in pediatric patients with NF2 continues to develop as more such reports are published.
NF2 is a rare disorder due to heterozygous mutations in the homonymous gene. Affected patients develop bilateral acoustic schwannomas and are prone to develop central and peripheral meningiomas, ependymomas, and neurinomas. They often present ophthalmological and dermatological findings, some of which are congenital.
We are profoundly grateful to the patient and his parents for their collaboration and consent to publish.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent was obtained from patient’s parents.
- 2.Morris KA, Golding JF, Axon PR, Afridi S, Blesing C, Ferner RE, Halliday D, Jena R, Pretorius PM, Evans DG, McCabe M, Parry A, UK NF2 Research group (2016) Bevacizumab in neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluation. Neurooncol Pract 3(4):281–289PubMedPubMedCentralGoogle Scholar